The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients
Open accessAbstract
Depression and anxiety are common comorbidities in breast cancer patients. Whether depression and anxiety are associated with breast cancer progression or mortality is unclear. Herein, based on a systematic literature search, 17 eligible studies involving 282,203 breast cancer patients were included. The results showed that depression was associated with cancer recurrence [1.24 (1.07, 1.43)], all-cause mortality [1.30 (1.23, 1.36)], and cancer-specific mortality [1.29 (1.11, 1.49)]. However, anxiety was associated with recurrence [1.17 (1.02, 1.34)] and all-cause mortality [1.13 (1.07, 1.19)] but not with cancer-specific mortality [1.05 (0.82, 1.35)]. Comorbidity of depression and anxiety is associated with all-cause mortality [1.34 (1.24, 1.45)] and cancer-specific mortality [1.45 (1.11, 1.90)]. Subgroup analyses demonstrated that clinically diagnosed depression and anxiety, being female and of younger age (<60 years), and shorter follow-up duration (≤5 years) were related to a poorer prognosis. Our study highlights the critical role of depression/anxiety as an independent factor in predicting breast cancer recurrence and survival. Further research should focus on a favorable strategy that works best to improve outcomes among breast cancer patients with mental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated anxiety predicts nonadherence to recommended therapies, [23][24][25] higher use and costs of medical care, [26][27][28] and possibly cancer recurrence.29”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analyses report an overall global prevalence of anxiety in BC patients at around 41.9%, with signifcantly higher rates in developing countries like Iran, where it reaches 65.5% [11,12].”
From Internet‐Based Telecare and Bibliotherapy Delivery of Acceptance and Commitment Therapy for Reducing Anxiety and Depression in Breast Cancer Patients: A Randomized Controlled Trial. (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kamiya, A., Hayama, Y., Kato, S., Shimomura, A., Shimomura, T., Irie, K., Kaneko, R., Yanagawa, Y., Kobayashi, K., & Ochiya, T. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0430-3 · Cited by 288
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“All of the selected articles were examined in terms of quality based on the Newcastle–Ottawa Quality Assessment Scale for cohort studies [41].”
BackgroundRelation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353 · cited 1×
“This variation was also found in previous similar meta-analyses of the association between depression in cardiac patients and prognosis [57, 60].”
ResultChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citation
Cited by
Stress and cancer: mechanisms, significance and future directions
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E., & Ben-Eliyahu, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00395-5 · Cited by 348
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101155 · Cited by 316
“Volume 8 - Issue 2 - 2023 treatment, more advanced disease and ChT have all been shown to be significant risk factors for depression.(1,2) Furthermore, there is increasing evidence that higher tumour cell burden and treatment-related tissue destruction are associated with increased release of proinflammatory cytokines…”
BackgroundCarlson, L. E., Ismaila, N., Addington, E. L., Asher, G. N., Atreya, C., Balneaves, L. G., Bradt, J., Fuller-Shavel, N., Goodman, J., Hoffman, C. J., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00857 · Cited by 309
“This is important not only for improving overall psychosocial adjustment and quality of life, but because untreated depression and anxiety symptoms are consistently associated with higher overall mortality in people with cancer.(161,162) Interest among those diagnosed and treated for cancer in these complementary form…”
BackgroundManagement of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“Elevated anxiety predicts nonadherence to recommended therapies,(23-25) higher use and costs of medical care,(26-28) and possibly cancer recurrence.(29) As is the case for those without cancer, depression and anxiety usually co-occur.”
BackgroundIs cancer biology different in older patients?
Van Herck, Y., Feyaerts, A., Alibhai, S., Papamichael, D., Decoster, L., Lambrechts, Y., Pinchuk, M., Bechter, O., Herrera-Caceres, J., Bibeau, F., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00179-3 · Cited by 161
Metadata
- Authors
- Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z.
- Affiliations
- Guangzhou University of Chinese Medicine (CN)
- Corresponding author
- Wang, Zhiyu
- Venue
- Molecular Psychiatry
- Published
- 2020-08-20
- Volume
- 25
- Issue
- 12
- Pages
- 3186-3197
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC7714689
- OpenAlex
- W3057125992
- Cited by
- 512
- References
- 71
- Citations by year
- 2026: 90 · 2025: 118 · 2024: 116 · 2023: 82 · 2022: 73 · 2021: 31 · 2020: 2
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Guangdong Provincial Hospital of Traditional Chinese Medicine (81873306, 81703764, 81703749, 20181132, 2018KZDXM022, 2016A030306025, YN2018MJ07, 201904010407, 2018A030310506, YN2018QJ08, 20182044, 2017B030314166, 2017A030310213, 81573651, A1-2606-19-111-009, A1-3002-16-111-003)
- National Natural Science Foundation of China (A1-3002-16-111-003, 2016A030306025, 81703749, 81703764, 81573651, 2018KZDXM022, 81873306, 20181132, YN2018QJ08, YN2018MJ07, 81973526, A1-2606-19-111-009, 201904010407, 2017A030310213, 2017B030314166, 20182044, 2018A030310506)
- Natural Science Foundation of Guangdong Province (A1-3002-16-111-003, 2017B030314166, 81573651, 2017A030310213, 2018KZDXM022, 81703749, 20181132, YN2018MJ07, A1-2606-19-111-009, YN2018QJ08, 81703764, 2016A030306025, 20182044, 2018A030310506, 201904010407, 81873306)
- Department of Education of Guangdong Province (A1-2606-19-111-009, 81703749, 2016A030306025, 2017A030310213, 81573651, A1-3002-16-111-003, 20181132, 2018KZDXM022, 2017B030314166, 20182044, YN2018QJ08, 2018A030310506, 81703764, 201904010407, YN2018MJ07, 81873306)
- Guangzhou University of Chinese Medicine (QNYC20190101)
- Guangzhou University
- Science and Technology Planning Project of Guangdong Province (2017B030314166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- breast cancer, depression, anxiety, tumor recurrence, cancer-specific mortality, all-cause mortality, prognosis, psychiatric comorbidity, psychological distress
- MeSH terms
- Anxiety, Breast Neoplasms, Depression, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. https://app.cochat.ai/papers/10.1038/s41380-020-00865-6
- The paper
- Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z. (2020). Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry. https://doi.org/10.1038/s41380-020-00865-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.